Qiagen Nv Stock Performance
| QGEN Stock | USD 43.43 0.32 0.73% |
The company holds a Beta of 0.72, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Qiagen NV's returns are expected to increase less than the market. However, during the bear market, the loss of holding Qiagen NV is expected to be smaller as well. At this point, Qiagen NV has a negative expected return of -0.023%. Please make sure to check Qiagen NV's treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Qiagen NV performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Qiagen NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Qiagen NV is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (0.73) | Five Day Return 0.46 | Year To Date Return (3.49) | Ten Year Return 75.4 | All Time Return 2.1 K |
Forward Dividend Yield 0.0294 | Payout Ratio 0.6197 | Last Split Factor 962:1000 | Forward Dividend Rate 1.28 | Dividend Date 2024-01-30 |
1 | QIAGEN und Bode Technology treiben Nutzung der GEDmatch PRO Datenbank fr forensische genetische Genealogie voran | 09/23/2024 |
2 | QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications | 10/10/2024 |
3 | QIAGEN Receives FDA Clearance for QIAstat-Dx MeningitisEncephalitis Panel | 11/04/2024 |
4 | Is There An Opportunity With Qiagen N.V.s 31 percent Undervaluation | 11/07/2024 |
5 | Why Qiagen is a Top Value Stock for the Long-Term | 11/08/2024 |
6 | Dont Overlook Qiagen International Revenue Trends While Assessing the Stock | 11/11/2024 |
7 | QGEN Collaborates With McGill University Centre Stock to Gain | 11/13/2024 |
8 | Germany stocks mixed at close of trade DAX up 0.75 | 11/21/2024 |
9 | Heres Why Qiagen is a Strong Momentum Stock | 11/25/2024 |
10 | QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis | 11/27/2024 |
11 | Heres Why Qiagen is a Strong Value Stock | 11/29/2024 |
| Begin Period Cash Flow | 730.7 M |
Qiagen |
Qiagen NV Relative Risk vs. Return Landscape
If you would invest 4,428 in Qiagen NV on September 1, 2024 and sell it today you would lose (85.00) from holding Qiagen NV or give up 1.92% of portfolio value over 90 days. Qiagen NV is currently does not generate positive expected returns and assumes 1.2582% risk (volatility on return distribution) over the 90 days horizon. In different words, 11% of stocks are less volatile than Qiagen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Qiagen NV Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Qiagen NV's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Qiagen NV, and traders can use it to determine the average amount a Qiagen NV's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0183
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | QGEN |
Estimated Market Risk
| 1.26 actual daily | 11 89% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Qiagen NV is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Qiagen NV by adding Qiagen NV to a well-diversified portfolio.
Qiagen NV Fundamentals Growth
Qiagen Stock prices reflect investors' perceptions of the future prospects and financial health of Qiagen NV, and Qiagen NV fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Qiagen Stock performance.
| Return On Equity | 0.0257 | ||||
| Return On Asset | 0.0484 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 10.16 B | ||||
| Shares Outstanding | 222.26 M | ||||
| Price To Earning | 24.32 X | ||||
| Price To Book | 2.75 X | ||||
| Price To Sales | 4.91 X | ||||
| Revenue | 1.97 B | ||||
| Gross Profit | 1.44 B | ||||
| EBITDA | 688.55 M | ||||
| Net Income | 341.3 M | ||||
| Cash And Equivalents | 1.89 B | ||||
| Cash Per Share | 8.31 X | ||||
| Total Debt | 1.61 B | ||||
| Debt To Equity | 0.69 % | ||||
| Current Ratio | 1.84 X | ||||
| Book Value Per Share | 15.88 X | ||||
| Cash Flow From Operations | 459.45 M | ||||
| Earnings Per Share | 0.45 X | ||||
| Market Capitalization | 9.65 B | ||||
| Total Asset | 6.12 B | ||||
| Retained Earnings | 2.46 B | ||||
| Working Capital | 1.07 B | ||||
| Current Asset | 193.04 M | ||||
| Current Liabilities | 81.49 M | ||||
About Qiagen NV Performance
By examining Qiagen NV's fundamental ratios, stakeholders can obtain critical insights into Qiagen NV's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Qiagen NV is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 195.87 | 187.92 | |
| Return On Tangible Assets | 0.11 | 0.09 | |
| Return On Capital Employed | 0.09 | 0.11 | |
| Return On Assets | 0.06 | 0.06 | |
| Return On Equity | 0.09 | 0.10 |
Things to note about Qiagen NV performance evaluation
Checking the ongoing alerts about Qiagen NV for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Qiagen NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Qiagen NV generated a negative expected return over the last 90 days | |
| Qiagen NV is unlikely to experience financial distress in the next 2 years | |
| Qiagen NV has a strong financial position based on the latest SEC filings | |
| Over 88.0% of the company shares are owned by institutional investors | |
| Latest headline from zacks.com: Heres Why Qiagen is a Strong Value Stock |
- Analyzing Qiagen NV's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Qiagen NV's stock is overvalued or undervalued compared to its peers.
- Examining Qiagen NV's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Qiagen NV's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Qiagen NV's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Qiagen NV's stock. These opinions can provide insight into Qiagen NV's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qiagen NV. If investors know Qiagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qiagen NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.255 | Earnings Share 0.45 | Revenue Per Share 8.841 | Quarterly Revenue Growth 0.055 | Return On Assets 0.0484 |
The market value of Qiagen NV is measured differently than its book value, which is the value of Qiagen that is recorded on the company's balance sheet. Investors also form their own opinion of Qiagen NV's value that differs from its market value or its book value, called intrinsic value, which is Qiagen NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qiagen NV's market value can be influenced by many factors that don't directly affect Qiagen NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Qiagen NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Qiagen NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qiagen NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.